Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts

BACKGROUND: Type 2 diabetes mellitus increases the risk of sarcopenia, which is characterized by decreased muscle mass, strength, and function. However, there are no effective drugs to treat diabetic sarcopenia, and its underlying mechanism remains unknown. Here, we aimed to determine whether the GL...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Fengyi, Wu, Wenyan, Fan, Xingyu, Zhong, Xing, Wang, Nuojin, Wang, Yue, Pan, Tianrong, Du, Yijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425251/
https://www.ncbi.nlm.nih.gov/pubmed/37584041
http://dx.doi.org/10.1155/2023/9926462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425251/
https://www.ncbi.nlm.nih.gov/pubmed/37584041
http://dx.doi.org/10.1155/2023/9926462

Ejemplares similares